Employees: NN (None)Legal category: SCA (commandite par actions)Size: PMECreation date: 2018-08-06 (7 years)Status: ActiveBusiness sector: Services administratifs combinés de bureauLocation: LE BEAUSSET (83330), Var
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
HEALTH-E-INNOV : revenue, balance sheet and financial ratios
HEALTH-E-INNOV is a French company
founded 7 years ago,
specialized in the sector Services administratifs combinés de bureau.
Based in LE BEAUSSET (83330),
this company of category PME
shows in 2024 a net income positive of 63 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - HEALTH-E-INNOV (SIREN 841790785)
Indicator
2024
2023
2022
2021
Revenue
N/C
N/C
N/C
N/C
Net income
62 660 €
-29 879 €
-15 467 €
-5 385 €
EBITDA
-31 090 €
-52 237 €
-26 021 €
-32 274 €
Net margin
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, HEALTH-E-INNOV generates positive net income of 63 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
EBITDA (2024)
?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity
-31 090 €
EBIT (2024)
?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals
-29 116 €
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
62 660 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 6805%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 1%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
6805.009%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
1.448%
Repayment capacity (2024)
?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent 3-5 years : Fair > 5 years : Warning
-12.777
Solvency indicators evolution HEALTH-E-INNOV
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2021
2022
2023
2024
Debt ratio
-10285.934
-3355.56
-1500.67
6805.009
Financial autonomy
-0.982
-3.072
-7.139
1.448
Repayment capacity
49.379
62.786
-16.543
-12.777
Cash flow / Revenue
None%
None%
None%
None%
Sector positioning
Debt ratio
6805.012024
2022
2023
2024
Q1: 0.0
Med: 11.23
Q3: 90.41
Watch+51 pts over 3 years
In 2024, the debt ratio of HEALTH-E-INNOV (6805.01) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
Financial autonomy
1.45%2024
2022
2023
2024
Q1: 5.18%
Med: 39.1%
Q3: 79.71%
Average
In 2024, the financial autonomy of HEALTH-E-INNOV (1.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
-12.78 years2024
2022
2023
2024
Q1: 0.0 years
Med: 0.02 years
Q3: 2.9 years
Excellent-50 pts over 3 years
In 2024, the repayment capacity of HEALTH-E-INNOV (-12.78) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
Interest coverage (2024)
?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable 1.5-3 : Acceptable < 1.5 : Risk
-375.095
Liquidity indicators evolution HEALTH-E-INNOV
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2021
2022
2023
2024
Liquidity ratio
None
None
None
None
Interest coverage
-84.495
-159.098
-163.244
-375.095
Sector positioning
Interest coverage
-375.1x2024
2022
2023
2024
Q1: -24.69x
Med: 0.0x
Q3: 0.2x
Average
In 2024, the interest coverage of HEALTH-E-INNOV (-375.1x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Positioning of HEALTH-E-INNOV in its sector
Comparison with sector Services administratifs combinés de bureau
Valuation estimate
Based on 173 transactions of similar company sales
(all years),
the value of HEALTH-E-INNOV is estimated at
220 828 €
(range 77 448€ - 597 258€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
173 transactions
77k€220k€597k€
220 828 €Range: 77 448€ - 597 258€
NAF 5 all-time
Valuation method used
Net Income Multiple
62 660 €
×
3.5x
=220 828 €
Range: 77 449€ - 597 259€
Only this financial indicator is available for this company.
How is this estimate calculated?
This estimate is based on the analysis of 173 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Services administratifs combinés de bureau)
Compare HEALTH-E-INNOV with other companies in the same sector:
The revenue of HEALTH-E-INNOV is not publicly disclosed (confidential accounts filed with INPI).
Is HEALTH-E-INNOV profitable?
Yes, HEALTH-E-INNOV generated a net profit of 63 k€ in 2024.
Where is the headquarters of HEALTH-E-INNOV ?
The headquarters of HEALTH-E-INNOV is located in LE BEAUSSET (83330), in the department Var.
Where to find the tax return of HEALTH-E-INNOV ?
The tax return of HEALTH-E-INNOV is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does HEALTH-E-INNOV operate?
HEALTH-E-INNOV operates in the sector Services administratifs combinés de bureau (NAF code 82.11Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart